Pharmafile Logo

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this most interesting of seasons.

- PMLiVE

In our new whitepaper, we share the current challenges and priorities that digital pharma leaders are finding in 2024.

Connectivity underpins innovation and efficiency, enabling improved outcomes for patients and HCPs.

Our latest research reveals the need for increased connection across the pharma sector — linking data with actionable insights, joining up internal teams, improving interactions between end users and providers, connecting digital systems and platforms, and aligning long-term goals with short-term priorities.

Drawing on the survey data, along with opinions from expert contributors and Graphite’s own sector experience, we explore how pharma teams can overcome challenges to achieve success with their digital solutions and strategies.

Based on first-hand insight from pharma leaders working within Commercial, Medical, Marketing and Digital roles across the USA and Europe.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...

How to successfully manage change and enable digital transformation within pharma

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Ensuring a seamless transition from design to development: Strategies for successful collaboration

When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.

How user research will help you create better digital products, whatever stage you’re at

User research provides valuable insight that will help you create better digital products and services, whatever stage you’re at.

Advancing digital engagement in pharma and healthcare: 2024 focus areas

6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

Building trust with HCPs: 6 takeaways from our industry webinar

Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.

Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital

Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...

What are design systems and how can they help you elevate your digital products?

Design Systems aren’t new, but the potential to utilise them to improve the way in which teams produce digital products is still untapped for many in the pharmaceutical and healthcare...